Navigation Links
Young Pop Star's Emphysema Startles Experts
Date:6/23/2008

But Amy Winehouse's reported diagnosis is a reminder of the damage drugs or cigarettes can do to lungs, they say

MONDAY, June 23 (HealthDay News) -- The shocking revelation by her father that 24-year-old British singer-songwriter Amy Winehouse may have a mild form of emphysema leaves experts with more questions than answers.

It's possible that Winehouse, in addition to her well-publicized use of drugs and cigarettes, has a congenital condition that contributed to her current crisis, one lung doctor said.

"If you see emphysema in a young person, you have to think of that," said Dr. Len Horovitz, a pulmonary specialist with Lenox Hill Hospital in New York City.

Dr. Norman Edelman, chief medical officer of the American Lung Association, added, "Generally, we don't really see emphysema until a person is in their 40s, but in a small number of people it could occur much earlier, especially in someone who smoked a long time."

"There's also the possibility -- not a probability -- that she's got a genetic variation. Five percent of people with emphysema have a genetic predisposition," Edelman said.

According to the Associated Press, Winehouse apparently collapsed at her north London home last Monday and was admitted into a London hospital, where she has been all week.

Winehouse's father, Mitch Winehouse, told the London Sunday Mirror that his daughter was told she would have to wear an oxygen mask unless she stops smoking drugs and cigarettes.

However, he has since modified that statement. According to MTV News, Mitch Winehouse told BBC 1 Radio on Monday that his daughter fainted at her home on June 16 and has been diagnosed with what he called "a small amount of emphysema." The soul singer's lungs do show a small amount of scarring, but her illness has not progressed "too far," her father said.

"It's not irreparable. Really, she can't eve
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Younger Patients Seeking More Aesthetic Treatments
2. 6th Annual Young-Onset Parkinsons Network Conference
3. Damon Runyon Cancer Research Foundation awards $2.25M to 5 top young clinical investigators
4. Journal STEM CELLS Presents 3rd Annual Young Investigator Award at International Stem Cell Symposium
5. Damon Runyon Cancer Research Foundation awards prestigious fellowships to 14 top young investigators
6. Diabetes Drug May Prevent Early Puberty in Young Girls
7. Rutgers scientist receives prestigious Young Investigator Award
8. Mariner Zac Sunderland Sets Sail on Quest to Become the Youngest to Circumnavigate the Globe Solo
9. Managing symptoms by mobile phone may revolutionize cancer care for young people
10. Experts highlight gaps in knowledge on caring for survivors of teenage and young adult cancers
11. UNICEF & Merck Partner to Protect 100,000 Children and Young People Against Mumps Epidemic
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Young Pop Star's Emphysema Startles Experts
Young Pop Star's Emphysema Startles Experts
Other Medicine News:Health News:Cord Blood America Reports First Quarter Financial Results; Gross Profits Increase 2Health News:National Ad Campaign Highlights Patient Ratings For More Than 1,000 Local U.S. Hospitals 2Health News:National Ad Campaign Highlights Patient Ratings For More Than 1,000 Local U.S. Hospitals 3Health News:The Children's Hospital of Philadelphia Opens the World's First Delivery Unit for Mothers Diagnosed with Birth Defects in Fetus 2Health News:The Children's Hospital of Philadelphia Opens the World's First Delivery Unit for Mothers Diagnosed with Birth Defects in Fetus 3Health News:The Children's Hospital of Philadelphia Opens the World's First Delivery Unit for Mothers Diagnosed with Birth Defects in Fetus 4Health News:Mayo Clinic Research Shows U.S. Intensive Care Units' Prevention of Pneumonia in Critically-ill Patients Generally Strong; Identifies Area of Improvement 2Health News:Mayo Clinic Research Shows U.S. Intensive Care Units' Prevention of Pneumonia in Critically-ill Patients Generally Strong; Identifies Area of Improvement 3Health News:Concomitant use of Perforomist & tiotropium -- significant improvements -- COPD 2Health News:Concomitant treatment with nebulized formoterol fumarate & tio-significant improvements -- COPD 2Health News:Concomitant treatment with nebulized formoterol fumarate & tio-significant improvements -- COPD 3Health News:Concomitant treatment with nebulized formoterol fumarate & tio-significant improvements -- COPD 4
Breaking Medicine Technology:Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA 2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4586 1VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA 2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4586 2VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA 2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4586 3VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA 2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4586 4VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA 2291 and Phase 3 Outcome Trial in Cardiovascular Disease 4586 5Jubilant to Work With Endo Pharmaceuticals on Drug Development 12582 1Jubilant to Work With Endo Pharmaceuticals on Drug Development 12582 2Jubilant to Work With Endo Pharmaceuticals on Drug Development 12582 3XELR8 Holdings Inc Hires Vice President of Strategy and Network Development 48585 1XELR8 Holdings Inc Hires Vice President of Strategy and Network Development 48585 2XELR8 Holdings Inc Hires Vice President of Strategy and Network Development 48585 3
Other Medicine Technology:Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 2Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 3Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 4Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 5Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 6Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions 7New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 2New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 3New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 4New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 5New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 6New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months 7